MEK7 Polyclonal Antibody, Biotin Conjugated, Rabbit

Catalog Number: BSS-BS-1979R-BIOTIN
Article Name: MEK7 Polyclonal Antibody, Biotin Conjugated, Rabbit
Biozol Catalog Number: BSS-BS-1979R-BIOTIN
Supplier Catalog Number: bs-1979R-Biotin
Alternative Catalog Number: BSS-BS-1979R-BIOTIN-100
Manufacturer: Bioss
Host: Rabbit
Category: Antikörper
Application: ELISA, IHC-Fr, IHC-P, WB
Species Reactivity: Human
Conjugation: Biotin
Alternative Names: MEK, MKK7, JNKK2, MEK 7, MAPKK7, PRKMK7, SAPKK4, SAPKK-4, Dual specificity mitogen-activated protein kinase kinase 7, MAP kinase kinase 7, MAPKK 7, JNK-activating kinase 2, MAPK/ERK kinase 7, Stress-activated protein kinase kinase 4, SAPK kinase 4, c-Jun N-terminal kinase kinase 2, JNK kinase 2, JNKK 2, MAP2K7, MEK7, SKK4
Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The monophosphorylation of JNKs on the Thr residue is sufficient to increase JNK activity indicating that MAP2K7/MKK7 is important to trigger JNK activity, while the additional phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal JNK activation. Has a specific role in JNK signal transduction pathway activated by proinflammatory cytokines. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.
Clonality: Polyclonal
Concentration: 1ug/ul
NCBI: 5609
UniProt: O14733
Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Source: KLH conjugated synthetic peptide derived from human MKK7
Target: MEK7
Application Dilute: WB(1:300-5000), ELISA(1:500-1000), IHC-P(1:200-400), IHC-F(1:100-500)